Literature DB >> 18505822

Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density.

Kristina Ellwanger1, Hiroaki Saito, Philippe Clément-Lacroix, Nicole Maltry, Joachim Niedermeyer, Woon Kyu Lee, Roland Baron, Georges Rawadi, Heiner Westphal, Christof Niehrs.   

Abstract

Kremen1 and Kremen2 (Krm1 and Krm2) are transmembrane coreceptors for Dickkopf1 (Dkk1), an antagonist of Wnt/beta-catenin signaling. The physiological relevance of Kremen proteins in mammals as Wnt modulators is unresolved. We generated and characterized Krm mutant mice and found that double mutants show enhanced Wnt signaling accompanied by ectopic postaxial forelimb digits and expanded apical ectodermal ridges. Triple mutant Krm1(-/-) Krm2(-/-) Dkk1(+/-) mice show enhanced growth of ectopic digits, indicating that Dkk1 and Krm genes genetically interact during limb development. Wnt/beta-catenin signaling also plays a critical role in bone formation. Single Krm mutants show normal bone formation and bone mass, while double mutants show increased bone volume and bone formation parameters. Our study provides the first genetic evidence for a functional interaction of Kremen proteins with Dkk1 as negative regulators of Wnt/beta-catenin signaling and reveals that Kremen proteins are not universally required for Dkk1 function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505822      PMCID: PMC2493355          DOI: 10.1128/MCB.00222-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.

Authors:  Frederic Morvan; Kim Boulukos; Philippe Clément-Lacroix; Sergio Roman Roman; Isabelle Suc-Royer; Béatrice Vayssière; Patrick Ammann; Patrick Martin; Sonia Pinho; Philippe Pognonec; Patrick Mollat; Christof Niehrs; Roland Baron; Georges Rawadi
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

2.  Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction.

Authors:  Gary Davidson; Wei Wu; Jinlong Shen; Josipa Bilic; Ursula Fenger; Peter Stannek; Andrei Glinka; Christof Niehrs
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

Review 3.  Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.

Authors:  Donald A Glass; Gerard Karsenty
Journal:  Curr Top Dev Biol       Date:  2006       Impact factor: 4.897

Review 4.  Wnt/beta-catenin signaling in development and disease.

Authors:  Hans Clevers
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

Review 5.  Function and biological roles of the Dickkopf family of Wnt modulators.

Authors:  C Niehrs
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

6.  R-spondin3 is required for mouse placental development.

Authors:  Motoko Aoki; Michihiro Mieda; Toshio Ikeda; Yoshio Hamada; Harukazu Nakamura; Hitoshi Okamoto
Journal:  Dev Biol       Date:  2006-08-10       Impact factor: 3.582

7.  R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling.

Authors:  Qiou Wei; Chika Yokota; Mikhail V Semenov; Brad Doble; Jim Woodgett; Xi He
Journal:  J Biol Chem       Date:  2007-03-30       Impact factor: 5.157

8.  A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice.

Authors:  Natalie A Sims; Philippe Clément-Lacroix; Dominique Minet; Caroline Fraslon-Vanhulle; Martine Gaillard-Kelly; Michèle Resche-Rigon; Roland Baron
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression.

Authors:  Ju-Suk Nam; Taryn J Turcotte; Peter F Smith; Sangdun Choi; Jeong Kyo Yoon
Journal:  J Biol Chem       Date:  2006-03-16       Impact factor: 5.157

10.  The Wnt signaling antagonist Kremen1 is required for development of thymic architecture.

Authors:  Masako Osada; Emi Ito; Hector A Fermin; Edwin Vazquez-Cintron; Tadmiri Venkatesh; Roland H Friedel; Mark Pezzano
Journal:  Clin Dev Immunol       Date:  2006 Jun-Dec
View more
  48 in total

1.  Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo.

Authors:  Helmut Glantschnig; Richard A Hampton; Ping Lu; Jing Z Zhao; Salvatore Vitelli; Lingyi Huang; Peter Haytko; Tara Cusick; Cheryl Ireland; Stephen W Jarantow; Robin Ernst; Nan Wei; Pascale Nantermet; Kevin R Scott; John E Fisher; Fabio Talamo; Laura Orsatti; Alfred A Reszka; Punam Sandhu; Donald Kimmel; Osvaldo Flores; William Strohl; Zhiqiang An; Fubao Wang
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

Review 2.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 3.  Dickkopf1: a tumor suppressor or metastasis promoter?

Authors:  Mitchell E Menezes; Daniel J Devine; Lalita A Shevde; Rajeev S Samant
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

Review 4.  Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis.

Authors:  Wanqing Xie; Lijiang Zhou; Shan Li; Tianqian Hui; Di Chen
Journal:  Ann N Y Acad Sci       Date:  2015-12-02       Impact factor: 5.691

Review 5.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

6.  Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.

Authors:  Rongrong Zhang; Babatunde O Oyajobi; Stephen E Harris; Di Chen; Christopher Tsao; Hong-Wen Deng; Ming Zhao
Journal:  Bone       Date:  2012-09-29       Impact factor: 4.398

Review 7.  LRP5 and LRP6 in development and disease.

Authors:  Danese M Joiner; Jiyuan Ke; Zhendong Zhong; H Eric Xu; Bart O Williams
Journal:  Trends Endocrinol Metab       Date:  2013-01       Impact factor: 12.015

Review 8.  Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.

Authors:  Laura Novellasdemunt; Pedro Antas; Vivian S W Li
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-19       Impact factor: 4.249

9.  Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.

Authors:  Jochen Schulze; Sebastian Seitz; Hiroaki Saito; Michael Schneebauer; Robert P Marshall; Anke Baranowsky; Bjoern Busse; Arndt F Schilling; Felix W Friedrich; Joachim Albers; Alexander S Spiro; Jozef Zustin; Thomas Streichert; Kristina Ellwanger; Christof Niehrs; Michael Amling; Roland Baron; Thorsten Schinke
Journal:  PLoS One       Date:  2010-04-27       Impact factor: 3.240

10.  Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation.

Authors:  Yonghe Li; Wenyan Lu; Taj D King; Chia-Chen Liu; Gautam N Bijur; Guojun Bu
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.